US$ 22.60
dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments agonists are increasingly used to treat type 2 and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal dr. reddy's labs glp-1 receptor
Description
Poly-agonists : Drugs combining GLP-1 with other hormones (GIP, glucagon, amylin) to potentially increase weight loss

Liu J, Bai R, Chai Z, Cooper ME, Zimmet PZ, Zhang L
Gilhus NE, Deuschl G

[DOI] [PubMed] [Google Scholar] 42.Pratley R.E., Aroda V.R., Lingvay I., Ldemann J., Andreassen C., Navarria A

Patients should be educated about DKA symptoms (nausea, vomiting, abdominal pain, excessive thirst, frequent urination, fatigue, fruity-scented breath) and when to seek urgent care

World journal of diabetes, 9(8), 138140
